131 related articles for article (PubMed ID: 2468249)
21. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
[TBL] [Abstract][Full Text] [Related]
22. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
23. Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.
Ferrara JL; Daley JP; Burakoff SJ; Miller RA
J Immunol; 1987 Jun; 138(11):3598-603. PubMed ID: 3108369
[TBL] [Abstract][Full Text] [Related]
24. The role of HLA-DQ antigens in the induction of cytotoxic T lymphocytes.
Porubská S; Buc M; Bencová M; Sausová E
Folia Biol (Praha); 1993; 39(5):256-61. PubMed ID: 8206171
[TBL] [Abstract][Full Text] [Related]
25. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
26. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
27. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ
Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101
[TBL] [Abstract][Full Text] [Related]
28. Cellular immunologic in vitro studies of kidney and bone marrow transplantation: cytotoxic T cell activity--an advantage or disadvantage?
Goulmy E
Transplant Proc; 1988 Apr; 20(2):183-5. PubMed ID: 3284037
[No Abstract] [Full Text] [Related]
29. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
[TBL] [Abstract][Full Text] [Related]
31. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
Thiele DL; Charley MR; Calomeni JA; Lipsky PE
J Immunol; 1987 Jan; 138(1):51-7. PubMed ID: 2946780
[TBL] [Abstract][Full Text] [Related]
32. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
33. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
[No Abstract] [Full Text] [Related]
34. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
35. Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.
Davies JK; Koh MB; Lowdell MW
Biol Blood Marrow Transplant; 2004 Apr; 10(4):259-68. PubMed ID: 15077224
[TBL] [Abstract][Full Text] [Related]
36. The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.
van Rood JJ; Goulmy E; van Leeuwen A
Prog Clin Biol Res; 1987; 244():433-8. PubMed ID: 3310005
[No Abstract] [Full Text] [Related]
37. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
[TBL] [Abstract][Full Text] [Related]
38. No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.
Murata M; Emi N; Hirabayashi N; Hamaguchi M; Goto S; Wakita A; Tanimoto M; Saito H; Kodera Y; Morishita Y;
Int J Hematol; 2000 Oct; 72(3):371-5. PubMed ID: 11185997
[TBL] [Abstract][Full Text] [Related]
39. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
40. Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A.
Liem LM; van Noort JT; Goulmy E
Bone Marrow Transplant; 1996 Jul; 18(1):73-8. PubMed ID: 8831998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
